Project Grant R01DA064625
Award Date 4/1/26
Completion Date 1/31/31
Dollars Obligated $759K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- Federal Project Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 15, 2025, with a completion date of June 30, 2027. The award funds research to develop innovative photopharmacological tools for investigating tetrahydrocannabinol (THC) signaling mechanisms in brain reward circuits. The primary deliverable is the advancement...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Tulane University $1.34 million under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a five-year research project (September 1, 2025–May 31, 2030) investigating the impact of chronic prenatal tetrahydrocannabinol (THC) exposure on simian immunodeficiency virus (SIV)-associated inflammation and impairments in placental and fetal development. This Project Grant supports basic and translational...
- Federal Project Grant Award Summary The University of Washington received a $699,748 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal neurodevelopmental research on infants exposed to cannabis prenatally. The award, effective February 15, 2026, through November 30, 2030, supports an expanded research program that builds on existing prospectively-measured cannabis exposure data collected...
- Federal Project Grant Award Summary The University of Oregon received a $149,000 Project Grant award (effective July 1, 2025, through June 30, 2027) from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal secondary analysis examining the developmental trajectories of parasympathetic nervous system (PNS) functioning in children prenatally exposed to tobacco and/or cannabis. The research deliverables include multi-method,...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $761,367 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. This translational research project aims to identify and validate fetal central nervous system (CNS)-derived extracellular vesicle biomarkers as predictors of neurodevelopmental effects resulting from...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $791,990 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2025, with an ultimate completion date of April 30, 2030. The award funds a prospective, mechanistic randomized controlled study investigating the bidirectional relationships between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis....
- Federal Project Grant Award Summary Washington State University received a $639,915 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct fundamental neuroscience research examining the mechanistic underpinnings of cognitive inflexibility in offspring exposed to prenatal cannabis. The research, initiated February 15, 2026, and concluding December 31, 2030, employs a novel translationally relevant animal model...
- Federal Grant Award Summary Oregon Health & Science University received a $1.25 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic neuroscience research investigating the mechanisms linking adolescent social deprivation to substance use disorder vulnerability. The award, obligated on September 30, 2025, with an ultimate completion date of May 31, 2030, supports a five-year research...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $171,822 on July 15, 2025, to the University of Maryland, Baltimore to conduct the "Effects of Prenatal and Postnatal Cannabis Use on Lactation and Maternal Bonding (LAMB)" study, funded under CFDA 93.279 (Drug Use and Addiction Research Programs). The research will investigate the effects of cannabis use during pregnancy and the postpartum period on maternal attachment,...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Southern California a $196,236 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate clinician preconceptions about cannabis use during pregnancy and their impact on prenatal care quality. The award funds a five-year research initiative (through June 30, 2030) led by Dr. Rachel Carmen Ceasar that employs natural language processing and artificial...